Alnylam’s Phase 3 Clinical Trials with Givosiran [transcript][audio]
Segment Overview: Jeff Miller, General Manager of the Givosiran program at Alnylam discusses the ENVISION Alnylam Phase 3 trial of its investigational R...
263 articles
Segment Overview: Jeff Miller, General Manager of the Givosiran program at Alnylam discusses the ENVISION Alnylam Phase 3 trial of its investigational R...
Jason Stein, MD Presenter: Neal Howard Guest Bio: Jason Stein, MD, is an attending orthopaedic surgeon at the MedStar Union Memorial Hospital.
Arthur Kavanaugh discusses the recent (Oct 2017) FDA approval of SIMPONI ARIA ® (golimumab) as the first and only fully-human anti-tumor necrosis facto...
Mohammed Issa Presenter: Neal Howard Guest Bio: Dr. Learn more on Health Professional Radio.
Fuchs, MD, MPH, became Director of Yale Cancer Center and Physician-in-Chief of Smilow Cancer Hospital on January 1, 2017.
Bob Carter Presenter: Neal Howard Guest Bio: Bob S. Learn more on Health Professional Radio.
Michelle Miller Presenter: Tabetha Moreto Guests Bio: Dr Miller has over 20 years of experience in the bioscience industry, with focus on commercial dev...
Stern Presenter: Neal Howard Guests Bio: David Stern is the Chief Executive Officer of Symbiomix. Learn more on Health Professional Radio.
Guest: Fauad Hasad Presenter: Neal Howard Guests Bio: Fauad Hasan is the President and CEO at Bonti. Learn more on Health Professional Radio.
Jonathan Strober & Julie Presenter: Neal Howard Guests Bio: Dr. Learn more on Health Professional Radio.